← Back to guidelines
Otolaryngology (ENT)88 papers

Biphenotypic sinonasal sarcoma

Last edited: 4/14/2026

Overview

Biphenotypic sinonasal sarcoma is a rare and aggressive malignancy arising in the sinonasal tract, characterized by mixed epithelial and mesenchymal differentiation. Its rarity necessitates multidisciplinary management and specialized expertise 12.

Diagnosis

  • Histological Examination: Essential for confirming biphenotypic features, distinguishing from other sinonasal tumors like renal cell-like carcinomas 4.
  • Immunohistochemistry: Utilize markers such as CK7, EMA, vimentin, SOX10, S-100, and CA9 to aid in diagnosis 4.
  • Imaging Studies: CT and MRI to assess tumor extent and involvement of adjacent structures 1.
  • Molecular Characterization: Consider for prognostic and therapeutic guidance, though specific recommendations are not detailed in provided abstracts 1.
  • Management

  • Surgical Resection: Primary treatment, often requiring complex surgical approaches due to anatomic constraints 18.
  • Radiotherapy: Indicated for adjuvant or definitive treatment, tailored based on tumor characteristics and surgical outcomes 1.
  • Target Volumes: Critical to define based on histology, grade, risk of lymph node involvement, and surgical extent 1.
  • Fractionation: Specific fractionation schedules should be individualized but guided by multidisciplinary consensus 1.
  • Special Populations

  • No Specific Guidelines: Provided abstracts do not detail management variations for pregnancy, pediatrics, elderly, or specific comorbidities 1248.
  • Key Recommendations

  • Multidisciplinary Approach: Essential for optimal management due to the complexity and rarity of biphenotypic sinonasal sarcoma (Evidence: Expert opinion) 1.
  • Tailored Radiotherapy: Use radiotherapy based on detailed tumor characterization including histology, grade, and surgical margins (Evidence: Moderate) 1.
  • Surgical Expertise: Employ specialized surgical techniques to ensure complete resection while minimizing complications (Evidence: Expert opinion) 8.
  • References

    1 Larnaudie A, Delaby N, Marcy PY, Leleu T, Costes-Martineau V, Vergez S et al.. Radiotherapy of sinonasal cancers. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2022. link 2 Virk JS, Chan J, Dimitrov L, Williamson A, Sandison A, Weir J et al.. Sinonasal cancer: an overview of the emerging subtypes. The Journal of laryngology and otology 2020. link 3 Franchi A, Bishop JA, Coleman H, Flucke U, Licitra LF, Pendás JLL et al.. Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Archives of pathology & laboratory medicine 2019. link 4 Zhenwei-Chen, Zhaoming-Wang, Hongqi-Shi, Qinwei-Liu. Renal cell -like carcinoma of the nasal cavity: a case report and review of the literature. Diagnostic pathology 2017. link 5 Winford TW, Wallin JL, Clinger JD, Graham AM. Malpractice in treatment of sinonasal disease by otolaryngologists: a review of the past 10 years. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2015. link 6 Antunes MB, Becker SS. The role of local steroid injection for nasal polyposis. Current allergy and asthma reports 2010. link 7 Lydiatt DD, Sewell RK. Medical malpractice and sinonasal disease. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2008. link 8 Howard DJ, Lund VJ. The midfacial degloving approach to sinonasal disease. The Journal of laryngology and otology 1992. link

    Original source

    1. [1]
      Radiotherapy of sinonasal cancers.Larnaudie A, Delaby N, Marcy PY, Leleu T, Costes-Martineau V, Vergez S et al. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique (2022)
    2. [2]
      Sinonasal cancer: an overview of the emerging subtypes.Virk JS, Chan J, Dimitrov L, Williamson A, Sandison A, Weir J et al. The Journal of laryngology and otology (2020)
    3. [3]
      Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.Franchi A, Bishop JA, Coleman H, Flucke U, Licitra LF, Pendás JLL et al. Archives of pathology & laboratory medicine (2019)
    4. [4]
      Renal cell -like carcinoma of the nasal cavity: a case report and review of the literature.Zhenwei-Chen, Zhaoming-Wang, Hongqi-Shi, Qinwei-Liu Diagnostic pathology (2017)
    5. [5]
      Malpractice in treatment of sinonasal disease by otolaryngologists: a review of the past 10 years.Winford TW, Wallin JL, Clinger JD, Graham AM Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2015)
    6. [6]
      The role of local steroid injection for nasal polyposis.Antunes MB, Becker SS Current allergy and asthma reports (2010)
    7. [7]
      Medical malpractice and sinonasal disease.Lydiatt DD, Sewell RK Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2008)
    8. [8]
      The midfacial degloving approach to sinonasal disease.Howard DJ, Lund VJ The Journal of laryngology and otology (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG